Patents by Inventor Mark Robert Brann

Mark Robert Brann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Identification of ligands by selective amplification of cells transfected with receptors
    Patent number: 5955281
    Abstract: The invention is directed to a method for identifying substances acting as ligands for transfected receptors by using transfected markers to measure receptor/ligand interactions.
    Type: Grant
    Filed: November 7, 1997
    Date of Patent: September 21, 1999
    Assignee: Acadia Pharmaceuticals, Inc.
    Inventor: Mark Robert Brann
  • Identification of ligands by selective amplification of cells transfected with receptors
    Patent number: 5912132
    Abstract: The invention is directed to a method for identifying substances acting as ligands for transfected receptors by using transfected markers to measure receptor/ligand interactions.
    Type: Grant
    Filed: October 20, 1997
    Date of Patent: June 15, 1999
    Assignee: Acadia Pharmaceuticals, Inc.
    Inventor: Mark Robert Brann
  • Cloned human genes for muscarinic acetylcholine receptors and cells lines expressing same
    Patent number: 5747336
    Abstract: Clones of human genes for a plurality of different muscarinic acetylcholine receptors and stable cell lines homogeneously expressing a specific subtype of the receptors have been prepared. A method for screening muscarinic drugs has been described.
    Type: Grant
    Filed: August 29, 1994
    Date of Patent: May 5, 1998
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Tom I. Bonner, Mark Robert Brann, Noel J. Buckley
  • Identification of ligands by selective amplification of cells transfected with receptors
    Patent number: 5707798
    Abstract: The invention is directed to a method for identifying substances acting as ligands for transfected receptors by using transfected markers to measure receptor/ligand interactions.
    Type: Grant
    Filed: July 12, 1994
    Date of Patent: January 13, 1998
    Assignee: Novo Nordisk A/S
    Inventor: Mark Robert Brann